Pharmacokinetics and total removal of fosfomycin in two patients undergoing intermittent haemodialysis and extended dialysis: prescription needs to avoid under-dosing

J Antimicrob Chemother. 2016 Sep;71(9):2673-4. doi: 10.1093/jac/dkw187. Epub 2016 Jun 5.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Anti-Bacterial Agents / administration & dosage*
  • Anti-Bacterial Agents / pharmacokinetics*
  • Anti-Bacterial Agents / therapeutic use
  • Drug Prescriptions
  • Escherichia coli / drug effects
  • Female
  • Fosfomycin / administration & dosage*
  • Fosfomycin / pharmacokinetics*
  • Fosfomycin / therapeutic use
  • Humans
  • Male
  • Middle Aged
  • Practice Patterns, Physicians'
  • Renal Dialysis*
  • Renal Elimination

Substances

  • Anti-Bacterial Agents
  • Fosfomycin